Neurocrine Biosciences Inc

Common Name
Neurocrine Biosciences
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1,800
Ticker
NBIX
Exchange
NASDAQ/NGS
Description
Neurocrine Biosciences Inc. is a biopharmaceutical company that focuses on the discovery, development, and commercialization of innovative treatments for neurological and endocrine-related disorders. ...

Financial Statements of Neurocrine Biosciences

Below are the financial statements of Neurocrine Biosciences, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

All figures in millions of USD20242023
Current assets
Cash and cash equivalents
233a
251.1a
Available-for-sale debt securities
843.1a
780.5a
Accounts receivable
479.1a
439.3a
Inventory
57.4a
38.3a
Other current assets
112.1a
97.8a
Total current assets
1,724.7a
1,607a
Assets
Deferred tax assets
485.7a
362.6a
Available-for-sale debt securities
739.5a
687.5a
Right-of-use assets
509.4a
276.5a
Equity investments
124.8a
161.9a
Property and equipment, net
82.6a
70.8a
Intangible assets, net
36.5a
35.5a
Other noncurrent assets
15.5a
49.6a
Total assets
3,718.7a
3,251.4a
Current liabilities
Accounts payable and accrued liabilities
461.6a
448.8a
Convertible senior notes
0a
170.1a
Other current liabilities
46.1a
35.9a
Total current liabilities
507.7a
654.8a
Liabilities and stockholders’ equity
Noncurrent operating lease liabilities
455.1a
258.3a
Other noncurrent liabilities
166.2a
106.3a
Total liabilities
1,129a
1,019.4a
Stockholders’ equity
Preferred stock
0a
0a
Common stock
0.1a
0.1a
Additional paid-in capital
2,554.6a
2,382a
Accumulated other comprehensive income
5.8a
7a
Retained earnings (accumulated deficit)
29.2a
-157.1a
Total stockholders’ equity
2,589.7a
2,232a
Total liabilities and stockholders’ equity
3,718.7a
3,251.4a

Verified Sources Behind Neurocrine Biosciences’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Neurocrine Biosciences’s data sources below and access millions more through our Disclosure Search.

a. Neurocrine Biosciences's Annual Report 2024
Trace every data point back to Neurocrine Biosciences’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?